Free Cash Flow

Upbound Group's new CEO and CFO head to the prestigious ICR Conference. Investors await insights on growth, credit trends, and financial inclusion strategy.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

As Copa Holdings prepares its Q4 2025 results, investors and analysts will scrutinize if the airline can sustain its stellar performance and margins.

With its Q4 earnings approaching, all eyes are on Federal Realty to see if its premium retail strategy can sustain its record dividend amid market shifts.

As ENvue Medical prepares to ring the Nasdaq bell, a look at how its non-invasive tech for tube placement and pain relief is shaking up the MedTech world.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

With gold hitting record highs, investors are keenly awaiting Kinross's update on three critical US projects that could define its production for a decade.

At CES 2026, BLUETTI moves beyond portable power, unveiling smart home batteries, a sodium-ion first, and a vision for a decentralized energy grid.

Sana Biotechnology prepares for its pivotal J.P. Morgan update, balancing groundbreaking diabetes data against a ticking financial clock and fierce competition.

The market research tech firm secures a strategic investment from TA Associates to scale its AI-powered platform and redefine data quality standards.

Peachtree Group's new division closes nearly $30M in its first quarter, capitalizing on a growing credit gap in middle-market equipment finance.

A $7M auction saw a Purdey gun fetch $209K, revealing a red-hot market where history, craftsmanship, and investment potential drive record prices.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

New IoT solution from Clarios prevents costly trailer failures and protects cold chain goods by providing real-time battery health insights.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.

A new forecast warns of sub-1% growth as tariffs, labor shifts, and debt create an era of experimentation, urging investors to adapt and diversify.

CleanSpark boosts Bitcoin output by over 10% and pivots to AI data centers, all while helping stabilize the power grid in times of extreme demand.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

South Korea's Curogen secures major national funding and targets global partners at the JP Morgan conference, advancing novel therapies for IBD and HS.